期刊
FERTILITY AND STERILITY
卷 80, 期 2, 页码 300-304出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S0015-0282(03)00609-5
关键词
GnRH agonist; endometriosis; interleukin-6; endometriomas
Objective: To determine whether serum interleukin (IL)-6 can be measured in patients with ovarian endometriomas and whether these measurements are useful in managing this disease. Design: A controlled clinical study and an in vitro study. Setting: Department of Obstetrics and Gynecology, Tottori University, Japan. Patient(s): Twenty-two patients with ovarian endometriomas. Intervention(s): Laparoscopic cystectomy for ovarian endometriomas was performed. Gonadotropin-releasing hormone (GnRH) agonist was administered for 3 months in nine patients before laparoscopic surgery. Endometriotic stromal cells obtained from patients with endometriornas with or without GnRH agonist treatment were cultured. Main Outcome Measure(s): IL-6 concentrations in serum or supernatant of the cell culture were measured using ELISA. Result(s): The serum concentration of IL-6 in patients with endometriornas was higher at the time of diagnosis than in those without endometriomas. Laparoscopic surgery significantly reduced serum levels of IL-6. Serum IL-6 concentrations also decreased after treatment with GnRH agonist. IL-6 production was attenuated in the endometriotic stromal cells obtained from patients with GnRH agonist treatment compared with patients without such treatment. Conclusion(s): GnRH agonist treatment may decrease IL-6 production in endometriotic cells. Measurement of serum IL-6 concentrations may be of value in managing patients with endometrionnas. (C) 2003 by American Society for Reproductive Medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据